Bloomberg BNA’s Books Monitor
"Supreme Court Holds That Isolated DNA Is Not Patent Eligible, But Complimentary DNA (cDNA) Is Patent Eligible"
In Association for Molecular Pathology v. Myriad Genetics (formerly v. U.S. Patent & Trademark Office), the Court held that isolated deoxyribonucleic acid (DNA) is an unpatentable product of nature, while cDNA is a non-naturally occurring genetic sequence, and is patent eligible. Isolated DNA (or isolated genomic DNA) is DNA taken from a part of the entirety of an organism's hereditary information or chromosomes. Complementary DNA (cDNA) is DNA that is artificially synthesized from messenger RNA, which is genetic material transcribed from genomic DNA that becomes proteins.